SCHEMBL26465336

SCHEMBL26465336

CC(CCC(=O)OC1CCCCC1)(c1ccc(O)cc1)c1ccc(O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
ESR1 P03372 1/20 0.54
CYP3A4 P08684 1/20 0.54
ESR2 Q92731 1/20 0.54
NAAA Q02083 2/20 0.44
MIF P14174 2/20 0.44
CYP19A1 P11511 3/20 0.43
HSD17B10 Q99714 2/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
MAPK10 P53779 1/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10410235 0.84 NAAA (0.49) ALDH1A1ESR1CYP3A4ESR2NAAA
SCHEMBL3125861 0.76 ESR1 (0.67) ALDH1A1ESR1CYP3A4ESR2MIF
SCHEMBL13779872 0.76 NAAA (0.57) ALDH1A1NAAACYP19A1KDM4EHPGD
SCHEMBL27824205 0.76 CYP19A1 (0.50) ALDH1A1ESR1CYP3A4NAAAMIF
SCHEMBL26102432 0.76 CYP19A1 (0.55) ALDH1A1MIFCYP19A1HSD17B10ALOX15
SCHEMBL7122766 0.75 ESR1 (0.65) ALDH1A1ESR1CYP3A4ESR2MIF
SCHEMBL7675370 0.75 NAAA (0.56) ALDH1A1NAAACYP19A1KDM4EHPGD
SCHEMBL26453033 0.74 CYP19A1 (0.50) ALDH1A1ESR1ESR2MIFCYP19A1
SCHEMBL3131837 0.74 ESR1 (0.63) ALDH1A1ESR1CYP3A4ESR2MIF
SCHEMBL27888716 0.73 NAAA (0.54) ALDH1A1NAAACYP19A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4259610-B1 CATALYSTS FOR BENZOXAZINE LUXEMBOURG INST SCIENCE & TECH LIST (LU) 2024-09-18 EP disclosed
US-20240025867-A1 CATALYSTS FOR BENZOXAZINE LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST) (LU) 2024-01-25 US disclosed
EP-4259610-A1 CATALYSTS FOR BENZOXAZINE Luxembourg Institute of Science and Technology (LIST) (LU) 2023-10-18 EP disclosed
WO-2023074830-A1 AROMATIC POLYCARBONATE RESIN, POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE 出光興産株式会社 2023-05-04 WO disclosed
WO-2022122882-A1 CATALYSTS FOR BENZOXAZINE LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST) (LU) 2022-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025867-A1 CATALYSTS FOR BENZOXAZINE AOX1, XDH, FOS ALDH1A1 242/4885ESR1 668/4885CYP3A4 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.